InvestorsHub Logo
Followers 18
Posts 1054
Boards Moderated 0
Alias Born 12/07/2002

Re: Gcbr post# 17079

Saturday, 08/28/2004 11:13:24 PM

Saturday, August 28, 2004 11:13:24 PM

Post# of 82595
Arch, from what I have read (and I am not an expert by any means) it looks as if they can potentially "solve" any complex trait. Some are more difficult than others (things like schizophrenia are often mentioned in this context), but I think unless I have missed something that the only thing stopping them is financial resources to undertake the R&D and associated clinical trials. If they can get one classisifer to market that should potentially solve this problem for them and enable them to dispense with La Jolla. Statinome and Ovanome are the keys here.